Literature DB >> 22450362

Identification of two novel mutations in the first Sicilian APECED patient with no R203X mutation in AIRE gene and review of Italian APECED genotypes.

Mariella Valenzise1, Malgorzata Wasniewska, Silvestro Mirabelli, Filippo De Luca, Sara Cervato, Corrado Betterle.   

Abstract

UNLABELLED: Aims of the present study are: 1) to report an additional Sicilian patient with autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED), whose genotypic features are original, in that she is the first APECED patient with three coexisting mutations of Autoimmune Regulator (AIRE) gene, two of which had never been reported to date; 2) to review the genotypic epidemiology of APECED in Italy, in order to underline the great genetic heterogeneity of this disorder in Italian patients. Both the novel mutations of our new patient, named S107C and Q108fs respectively, were detected on exon 3 and were inherited by the mother, whereas the third one (T16M) was inherited by the father. Phenotypically, the present case is quite characteristic, in that she exhibited a classical clinical picture, with no original features.
CONCLUSIONS: a) this is the seventh Sicilian APECED patient identified to date, and the first one with no R203X mutation; b) our data confirm that distribution of mutations may considerably vary according to different geographical distribution, within the same country, thus suggesting a potential founder effect. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450362     DOI: 10.1016/j.gene.2012.03.032

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

Review 1.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy from the pediatric perspective.

Authors:  D Capalbo; N Improda; A Esposito; L De Martino; F Barbieri; C Betterle; C Pignata; M Salerno
Journal:  J Endocrinol Invest       Date:  2013-05-30       Impact factor: 4.256

2.  Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children.

Authors:  Mariella Valenzise; Tommaso Aversa; Giuseppina Salzano; Giuseppina Zirilli; Filippo De Luca; Maureen Su
Journal:  Ital J Pediatr       Date:  2017-01-19       Impact factor: 2.638

3.  Epidemiological and clinical peculiarities of polyglandular syndrome type 3 in pediatric age.

Authors:  Mariella Valenzise; Tommaso Aversa; Angiola Saccomanno; Filippo De Luca; Giuseppina Salzano
Journal:  Ital J Pediatr       Date:  2017-08-07       Impact factor: 2.638

4.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: insights into genotype-phenotype correlation.

Authors:  Donatella Capalbo; Lucia De Martino; Giuliana Giardino; Raffaella Di Mase; Iolanda Di Donato; Giancarlo Parenti; Pietro Vajro; Claudio Pignata; Mariacarolina Salerno
Journal:  Int J Endocrinol       Date:  2012-10-22       Impact factor: 3.257

Review 5.  APECED: A Paradigm of Complex Interactions between Genetic Background and Susceptibility Factors.

Authors:  Lucia De Martino; Donatella Capalbo; Nicola Improda; Federica D'Elia; Raffaella Di Mase; Roberta D'Assante; Ida D'Acunzo; Claudio Pignata; Mariacarolina Salerno
Journal:  Front Immunol       Date:  2013-10-23       Impact factor: 7.561

Review 6.  Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A "Rare" Manifestation in a "Rare" Disease.

Authors:  Alessandra Fierabracci
Journal:  Int J Mol Sci       Date:  2016-07-12       Impact factor: 5.923

7.  Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.

Authors:  S Garelli; M Dalla Costa; C Sabbadin; S Barollo; B Rubin; R Scarpa; S Masiero; A Fierabracci; C Bizzarri; A Crinò; M Cappa; M Valenzise; A Meloni; A M De Bellis; C Giordano; F Presotto; R Perniola; D Capalbo; M C Salerno; A Stigliano; G Radetti; V Camozzi; N A Greggio; F Bogazzi; I Chiodini; U Pagotto; S K Black; S Chen; B Rees Smith; J Furmaniak; G Weber; F Pigliaru; L De Sanctis; C Scaroni; C Betterle
Journal:  J Endocrinol Invest       Date:  2021-05-18       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.